Hanlon Investment Management Inc. Invests $601,000 in Cabot Co. (NYSE:CBT)

Hanlon Investment Management Inc. purchased a new stake in Cabot Co. (NYSE:CBT) in the 4th quarter, HoldingsChannel reports. The fund purchased 6,582 shares of the specialty chemicals company’s stock, valued at approximately $601,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. R Squared Ltd acquired a new stake in shares of Cabot in the fourth quarter worth $26,000. EverSource Wealth Advisors LLC boosted its position in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock worth $74,000 after acquiring an additional 219 shares during the period. GAMMA Investing LLC grew its stake in Cabot by 10.7% during the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after acquiring an additional 130 shares in the last quarter. Manchester Capital Management LLC increased its holdings in shares of Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock valued at $153,000 after purchasing an additional 1,584 shares during the period. Finally, KBC Group NV lifted its position in shares of Cabot by 43.1% in the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock worth $187,000 after purchasing an additional 616 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Trading Up 2.9 %

Cabot stock opened at $79.60 on Monday. Cabot Co. has a one year low of $73.63 and a one year high of $117.46. The company’s fifty day moving average price is $83.53 and its two-hundred day moving average price is $95.81. The company has a market capitalization of $4.32 billion, a price-to-earnings ratio of 10.57, a PEG ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CBT has been the topic of several research reports. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Mizuho dropped their price target on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 7th. UBS Group reduced their price objective on Cabot from $93.00 to $83.00 and set a “neutral” rating for the company in a research report on Monday, April 7th. Finally, StockNews.com downgraded Cabot from a “buy” rating to a “hold” rating in a research note on Wednesday, April 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $93.25.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.